BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 36889333)

  • 1. Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective, open-label, non-inferiority, randomised trial.
    Diletti R; den Dekker WK; Bennett J; Schotborgh CE; van der Schaaf R; Sabaté M; Moreno R; Ameloot K; van Bommel R; Forlani D; van Reet B; Esposito G; Dirksen MT; Ruifrok WPT; Everaert BRC; Van Mieghem C; Elscot JJ; Cummins P; Lenzen M; Brugaletta S; Boersma E; Van Mieghem NM;
    Lancet; 2023 Apr; 401(10383):1172-1182. PubMed ID: 36889333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial.
    Engstrøm T; Kelbæk H; Helqvist S; Høfsten DE; Kløvgaard L; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L;
    Lancet; 2015 Aug; 386(9994):665-71. PubMed ID: 26347918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing of Complete Revascularization with Multivessel PCI for Myocardial Infarction.
    Stähli BE; Varbella F; Linke A; Schwarz B; Felix SB; Seiffert M; Kesterke R; Nordbeck P; Witzenbichler B; Lang IM; Kessler M; Valina C; Dibra A; Rohla M; Moccetti M; Vercellino M; Gaede L; Bott-Flügel L; Jakob P; Stehli J; Candreva A; Templin C; Schindler M; Wischnewsky M; Zanda G; Quadri G; Mangner N; Toma A; Magnani G; Clemmensen P; Lüscher TF; Münzel T; Schulze PC; Laugwitz KL; Rottbauer W; Huber K; Neumann FJ; Schneider S; Weidinger F; Achenbach S; Richardt G; Kastrati A; Ford I; Maier W; Ruschitzka F;
    N Engl J Med; 2023 Oct; 389(15):1368-1379. PubMed ID: 37634190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes.
    Cui K; Lyu S; Liu H; Song X; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Tian J
    Cardiovasc Diabetol; 2019 Sep; 18(1):119. PubMed ID: 31530274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial.
    Holm NR; Mäkikallio T; Lindsay MM; Spence MS; Erglis A; Menown IBA; Trovik T; Kellerth T; Kalinauskas G; Mogensen LJH; Nielsen PH; Niemelä M; Lassen JF; Oldroyd K; Berg G; Stradins P; Walsh SJ; Graham ANJ; Endresen PC; Fröbert O; Trivedi U; Anttila V; Hildick-Smith D; Thuesen L; Christiansen EH;
    Lancet; 2020 Jan; 395(10219):191-199. PubMed ID: 31879028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial.
    Valgimigli M; Frigoli E; Leonardi S; Vranckx P; Rothenbühler M; Tebaldi M; Varbella F; Calabrò P; Garducci S; Rubartelli P; Briguori C; Andó G; Ferrario M; Limbruno U; Garbo R; Sganzerla P; Russo F; Nazzaro M; Lupi A; Cortese B; Ausiello A; Ierna S; Esposito G; Ferrante G; Santarelli A; Sardella G; de Cesare N; Tosi P; van 't Hof A; Omerovic E; Brugaletta S; Windecker S; Heg D; Jüni P;
    Lancet; 2018 Sep; 392(10150):835-848. PubMed ID: 30153988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome in patients with ST segment elevation myocardial infarction and multivessel disease treated with culprit-only, immediate, or staged multivessel percutaneous revascularization strategies: Insights from the REAL registry.
    Manari A; Varani E; Guastaroba P; Menozzi M; Valgimigli M; Menozzi A; Magnavacchi P; Franco N; Marzocchi A; Casella G
    Catheter Cardiovasc Interv; 2014 Nov; 84(6):912-22. PubMed ID: 24403174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.
    Mäkikallio T; Holm NR; Lindsay M; Spence MS; Erglis A; Menown IB; Trovik T; Eskola M; Romppanen H; Kellerth T; Ravkilde J; Jensen LO; Kalinauskas G; Linder RB; Pentikainen M; Hervold A; Banning A; Zaman A; Cotton J; Eriksen E; Margus S; Sørensen HT; Nielsen PH; Niemelä M; Kervinen K; Lassen JF; Maeng M; Oldroyd K; Berg G; Walsh SJ; Hanratty CG; Kumsars I; Stradins P; Steigen TK; Fröbert O; Graham AN; Endresen PC; Corbascio M; Kajander O; Trivedi U; Hartikainen J; Anttila V; Hildick-Smith D; Thuesen L; Christiansen EH;
    Lancet; 2016 Dec; 388(10061):2743-2752. PubMed ID: 27810312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial.
    Hahn JY; Song YB; Oh JH; Cho DK; Lee JB; Doh JH; Kim SH; Jeong JO; Bae JH; Kim BO; Cho JH; Suh IW; Kim DI; Park HK; Park JS; Choi WG; Lee WS; Kim J; Choi KH; Park TK; Lee JM; Yang JH; Choi JH; Choi SH; Gwon HC;
    Lancet; 2018 Mar; 391(10127):1274-1284. PubMed ID: 29544699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes of in-hospital staged revascularization versus culprit-only intervention for patients with ST-segment elevation myocardial infarction and multivessel disease.
    Cui K; Lyu S; Song X; Liu H; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Dai J; Tian J
    Coron Artery Dis; 2019 May; 30(3):188-195. PubMed ID: 30724818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immediate versus staged complete myocardial revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: A post hoc analysis of the randomized FLOWER-MI trial.
    Tea V; Morelle JF; Gallet R; Cayla G; Lemesle G; Lhermusier T; Dillinger JG; Ducrocq G; Angouvant D; Cottin Y; Chamandi C; le Bras A; Steg PG; Montalescot G; Nelson AC; Simon T; Chatellier G; Danchin N; Puymirat E;
    Arch Cardiovasc Dis; 2022 Oct; 115(10):496-504. PubMed ID: 36096979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial.
    Iglesias JF; Muller O; Heg D; Roffi M; Kurz DJ; Moarof I; Weilenmann D; Kaiser C; Tapponnier M; Stortecky S; Losdat S; Eeckhout E; Valgimigli M; Odutayo A; Zwahlen M; Jüni P; Windecker S; Pilgrim T
    Lancet; 2019 Oct; 394(10205):1243-1253. PubMed ID: 31488372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete versus culprit-only revascularisation in ST elevation myocardial infarction with multi-vessel disease.
    Bravo CA; Hirji SA; Bhatt DL; Kataria R; Faxon DP; Ohman EM; Anderson KL; Sidi AI; Sketch MH; Zarich SW; Osho AA; Gluud C; Kelbæk H; Engstrøm T; Høfsten DE; Brennan JM
    Cochrane Database Syst Rev; 2017 May; 5(5):CD011986. PubMed ID: 28470696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate or staged complete revascularisation in patients presenting with acute coronary syndrome by number of diseased vessels: a substudy of the BIOVASC randomised trial.
    Kakar H; Elscot JJ; Scarparo P; Den Dekker WK; Bennett J; Sabaté M; Esposito G; Amat-Santos I; Boersma E; Van Mieghem NM; Diletti R
    EuroIntervention; 2024 Apr; 20(8):e479-e486. PubMed ID: 38629415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trial.
    Kelbæk H; Høfsten DE; Køber L; Helqvist S; Kløvgaard L; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; De Backer O; Bang LE; Kofoed KF; Lønborg J; Ahtarovski K; Vejlstrup N; Bøtker HE; Terkelsen CJ; Christiansen EH; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Jensen LO; Clemmensen P; Grande P; Madsen JK; Torp-Pedersen C; Engstrøm T
    Lancet; 2016 May; 387(10034):2199-206. PubMed ID: 27053444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early versus delayed complete revascularisation in patients presenting with ST-segment elevation myocardial infarction and multivessel disease: a systematic review and meta-analysis of randomised controlled trials.
    Abouelmagd K; Tayel H; Atta A; Ladwiniec A; Ibrahim M
    Open Heart; 2022 Jun; 9(1):. PubMed ID: 35728889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of immediate complete vs staged complete revascularization in patients with acute coronary syndrome and multivessel disease.
    Singh S; Garg A; Chaudhary R; Rout A; Tantry US; Bliden K; Gurbel PA
    Cardiovasc Revasc Med; 2024 Mar; 60():1-8. PubMed ID: 37813709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial.
    Weisz G; Généreux P; Iñiguez A; Zurakowski A; Shechter M; Alexander KP; Dressler O; Osmukhina A; James S; Ohman EM; Ben-Yehuda O; Farzaneh-Far R; Stone GW;
    Lancet; 2016 Jan; 387(10014):136-45. PubMed ID: 26474810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bleeding episodes in "complete, staged" versus "culprit only" revascularisation in patients with multivessel disease and ST-segment elevation myocardial infarction: a DANAMI-3-PRIMULTI substudy.
    Sadjadieh G; Engstrøm T; Helqvist S; Høfsten DE; Køber L; Pedersen F; Clemmensen P; Jørgensen E; Saunamäki K; Tilsted HH; Kelbæk H; Holmvang L
    EuroIntervention; 2016 Nov; 12(10):1231-1238. PubMed ID: 27866133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and rationale of the COMPLETE trial: A randomized, comparative effectiveness study of complete versus culprit-only percutaneous coronary intervention to treat multivessel coronary artery disease in patients presenting with ST-segment elevation myocardial infarction.
    Mehta SR; Wood DA; Meeks B; Storey RF; Mehran R; Bainey KR; Nguyen H; Bangdiwala SI; Cairns JA;
    Am Heart J; 2019 Sep; 215():157-166. PubMed ID: 31326681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.